Pharma-Bio Serv (OTCMKTS:PBSV) Issues Quarterly Earnings Results, Beats Estimates By $0.35 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) released its quarterly earnings results on Monday. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.35, reports. The firm had revenue of $2.47 million for the quarter, compared to analysts’ expectations of $2.70 million. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%.

Pharma-Bio Serv Stock Performance

Shares of PBSV stock opened at $0.43 on Wednesday. Pharma-Bio Serv has a 52-week low of $0.31 and a 52-week high of $0.90. The firm has a market capitalization of $9.86 million, a PE ratio of -14.33 and a beta of 0.53. The stock has a fifty day simple moving average of $0.55 and a two-hundred day simple moving average of $0.57.

Pharma-Bio Serv Dividend Announcement

The firm also recently declared a dividend, which will be paid on Thursday, March 20th. Shareholders of record on Friday, February 28th will be paid a $0.075 dividend. The ex-dividend date is Friday, February 28th. Pharma-Bio Serv’s payout ratio is presently -250.00%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.